icon-folder.gif   Conference Reports for NATAP  
 
  ID Week 2024
October 16-19
Los Angeles, California

Back grey_arrow_rt.gif
 
 
 
Comparison of Renal Outcomes by Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) Containing Regimens for Prevention, and Treatment of HIV and/or HBV Treatment: A Systematic Literature Review and Meta-Analysis
 
 
  IDWeek; October 16-19, 2024; Los Angeles, CA, USA
 
Xi Liang1, Kyu Yun Park1, Haeseon Lee1, Connor Willis1, Tara Dhippayom2, Rachel Rogers4, Amy R. Weinberg4,
Julia Green4, Aileen Chi4, Nathorn Chaiyakunapruk1,3 1Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA; 2The
Prince Royal's College, Chiang Mai, Thailand; 3IDEAS Center, Veterans Affairs Salt Lake City Healthcare System,
Salt Lake City, Utah, USA; 4Gilead Sciences, Foster City, CA, USA

1022241

1022242

1022243

1022244

1022245

1022246

1022247